Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–#Analytics–One of the world’s leading analytics solutions provider, Quantzig, announces the completion of its recent article that presents comprehensive…
Company announces strategic collaboration with SR-Tiget MILAN–(BUSINESS WIRE)–#investing—Epsilen Bio, a biotechnology company developing transformative therapies for patients affected by underserved…
Denali Therapeutics and Sanofi have paused clinical studies with small molecule RIPK1 inhibitor DNL747 in Alzheimer’s disease and ALS, due to emerging evidence that higher levels of target inhibition may be required for maximizing efficacy, and certain challenges.
Leo Pharma on Monday presented new results from the PSO-LONG clinical trial, the first to provide long-term maintenance data for…
PCR Biosystems, the UK-based PCR experts, has launched qPCRBIO Probe 1-Step Virus Detect, a high-concentration 4x RT-qPCR kit designed specifically for ultra-sensitive, high-throughput detection of viral RNA sequences, including SARS-CoV-2.
Lonza and the Swedish company Cellink have partnered to offer a comprehensive 3-dimensional (3D) bioprinting solution designed to optimize and increase access to complete 3D cell culture workflows.
Faller Packaging has published its sustainability report for 2019. Under the title “New values for a successful collaboration”, the specialist company for pharmaceutical packaging looks back on a very successful business year and shows how economic, ecological and social responsibility go hand in hand in a company.
Cell-Easy, a start-up based in Toulouse specialized in stem cell therapy, has signed an agreement with the University Hospital Centre in Toulouse, and secured the authorization to open a pharmaceutical manufacturing plant dedicated to the production of stem cells – a first in France.
In the absence of ‘in person’ meetings, access to deep dive pharma insights are not on hold, and later this month experts will discuss how AI is rapidly evolving supply chain dynamics in a ground-breaking Pharmapack Europe webinar (June 17, 2020).
New subcutaneous, fixed-dose formulation of daratumumab reduces treatment time from hours to minutes, with comparable efficacy and fewer infusion-related reactions1,2…